Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.525 USD | -6.99% | -17.88% | -34.64% |
May. 16 | Replimune Group, Inc. Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
Apr. 08 | Replimune Group Provides Interim Results for Skin Cancer Therapy | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.64% | 365M | |
+41.37% | 54.04B | |
+43.57% | 41.96B | |
-1.29% | 41.92B | |
-7.59% | 28.35B | |
+12.44% | 26.35B | |
-22.33% | 19B | |
+7.83% | 13B | |
+28.88% | 12.28B | |
+24.94% | 12.19B |
- Stock Market
- Equities
- REPL Stock
- News Replimune Group, Inc.
- Transcript : Replimune Group, Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-09-2023 09